Cytotoxicity and antitumor properties of a marine compound, HESA-A, on cancer cells

Daru

Volumn 11, Issue 3, 2003, Pages 82-87

  Sadeghi Aliabadi, Hojjat ^a   Ahmadi, Amrollah ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antitumor agents; MTT assay; HESA A; Human cancer cells; Natural product

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; HESA A; METAL COMPLEX; METAL OXIDE; NATURAL PRODUCT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST ADENOCARCINOMA; CANCER CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG CYTOTOXICITY; ETHNOPHARMACOLOGY; HUMAN; HUMAN CELL; IRAN; LARYNX CARCINOMA; MOUSE; NONHUMAN; POWDER; TABLET; UTERINE CERVIX CARCINOMA; X RAY FLUORESCENCE;

EID: 0347337789     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Cancer Research Campaign. (1992) Cancer in the European community. Fact sheet, 5.1.
2. Valeriote, F., Putten, L. (1975) Proliferation-dependent cytotoxic action of anti-cancer agents: a review. Cancer Res. 35: 2619-2630.
3. Deonarain, M.P., Epenetos, A.A. (1994) Targeting enzymes for cancer therapy: old enzymes in new roles. British J. Cancer 70: 786-794.
4. Collier, D.A., Neidle, S. (1988) Synthesis, molecular modeling, DNA binding, and antitumor properties of some substituted amidoanthraquinones. J. Med. Chem. 31: 847-857.
5. Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55-63.
6. Carmichael, J., DeGraff, W.G., Gazdar, A.F., Minna, J.D., Mitchell, J.B. (1987) Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res. 47: 936-942.
7. Burk, R.f. (2002) Selenium, an antioxidant nutrient. Nutr. Clin. Care 5(2): 75-79.
8. Patel, V.J. (1978) Tantalum in diagnosing tumors of the ureter and renal pelvis: A preliminary report (author's translation). Urologe A. 17(3): 150-154.
9. Hall, I.H., Lackey, C.B., Kistler, T.D., Durham, R.W. Russell, J.M., Grimes, R.N. (2000) Antitumor activity of mono - and dimetallic transition metal carborane complexes of Ta, Fe, Co, Mo, or W. Anticancer Res. 20(4): 2345-2354.
10. Auvert, J., Botto, H., Pierquin, B., Mazeron, J.J. (1984) Iridium - 192 wiring after partial cystectomy as a treatment of small malignant bladder tumors. Prog. Clin. Biol. Res. 163B:87-93.
11. Chan, W.L., Wadhwa, S.S., Carolan, M.G. (2002) Gallium avid breast carcinoma. Australas Radiol. 46(3): 302-305.
12. Nose, H., Tsuboi, K., Hommura, S., Ishikawa, N. (1999) Thallium - 201 SPECT of orbital tumors. Orbit. 18(4): 261-266.
13. Luukkaa, M., Aitasalo, K., Pulkkinen, J., Lindholm, P., Valavaara, R., Grenman, R. (2002) Neodymium YAG contact laser in the treatment of cancer of the mobile tongue. Acta Otolaryngol. 122(3):318-322.
14. Melendez, E. (2002) Titanium complexes in cancer treatment. Crit. Rev. Oncol. Hematol. 42(3): 309-315.
15. Hiraoka, K., Komiya, S., Hamada, T., Zenmyo, M., Lnoue, A., (2001) Osteosarcoma cell apoptosis induced by selenium. J. Orthop. Res. 19(5): 809-814.
16. Fernandez - Banares, F., Cabre, E., Esteve, M., Mingorance, M.D., Abad - Lacruz, A., Lachica, M., Gil, A., Gassull, M.A. (2002) Serum selenium and risk of large size colorectal adenomas in a geographical area with a low selenium status. Am. J. Gastroenterol. 97(8): 2103-2108.
17. Wang, G.Q., Dawsey, S.M., Li, J.Y., Taylor, P.R., Li, B., Blot, W.J., Weinstein, W.M., Liu, F.S., Lewin, K.J., Wang, H., et al. (1994) Effects of vitamin / mineral supplementation on the prevalence of histological dysplasia and early cancer of the esophagus and stomach: results from the General Population Trial in Linxian, China. Cancer Epidemiol. Biomarkers Prev. 3(2): 161-166.
18. Blot, W.J., Li, J.Y., Taylor, P.R., Guo, W., Dawsey, S.M., Li, B. (1995) The Linxian trials: mortality rates by vitamin - mineral intervention group. Am. J. Clin. Nutr. 1424S-1426S.
19. Ji, Y.J., Xiao, B., Wang, Z.H., Cui, M.Z., Lu, Y.Y. (2000) The suppression effect of light rate earth elements on proliferation of two cancer cell lines. Biomed. Environ. Sci. 13(4): 287-292.
20. Wollina, U., Konrad, H., Karamfilov, T. (2001) Treatment of common warts and actinic keratoses by Er: YAG laser. J. Cutan. Laser Ther. 3(2):63-66.
21. Komemushi, A., Tanigawa, N., Okuda, Y., Kojima, H., Fujii, H., Shomura, Y., Sougawa, M., and Sawada, S. (2002) A new liquid embolic material for liver tumors. Acta Radiol. 43(2): 186.
22. Evangelou, A.M. (2002) Vanadium in cancer treatment. Crit. Rev. Oncol. Hematol. 42(3): 249-265.
23. Jouad, el. M., Thanh, X.D., Bouet, G., Bonneau, S., Khan, M.A. (2002) In vitro and in vivo effects of [Ni(M5FTSC)2C12] complex in cancer: preliminary tests. Anticancer Res. 22(3): 1713-1716.
24. Rozen, P., Lubin, F., Papo, N., Knaani, J., Farbstein, H., Farbstein, M., Zajicek, G. (2001) Calcium supplements interact significantly with long-term diet while suppressing rectal epithelial proliferation of adenoma patients. Cancer 15;91(4): 833-840.
25. Holbrook, T.L., Barrett-Connor, E. (1991) Calcium intake: covariates and confounders. Am. J. Clin. Nutr. 53(3): 741-744.
26. Costello, A.J. (2001) A randomized, controlled chemoprevention trial of selenium in familial prostate cancer: Rationale, recruitment, and design issues. Urology 57(4 Suppl 1): 182-184.
27. Chen, F., Vallyathan, V., Castranova, V., Shi, X. (2001) Cell apoptosis induced by carcinogenic metals. Mol. Cell Biochem. 222(1-2): 183-188.
28. Ding, M., Shi, X., Castranova, V., Vallyathan, V. (2000) Predisposing factors in occupational lung cancer: inorganic minerals and chromium. J. Environ. Pathol. Toxicol. Oncol. 19(1-2): 129-138.